BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Harvard Global Health Institute - ECPv6.5.1.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Harvard Global Health Institute
X-ORIGINAL-URL:https://globalhealth.harvard.edu
X-WR-CALDESC:Events for Harvard Global Health Institute
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260609T120000
DTEND;TZID=UTC:20260609T124500
DTSTAMP:20260821T053857
CREATED:20260126T144414Z
LAST-MODIFIED:20260603T184914Z
UID:10001047-1781006400-1781009100@globalhealth.harvard.edu
SUMMARY:Combining Evidence from Observational Studies and Population Surveys to Better Predict Cardiovascular Disease Risk
DESCRIPTION:Cardiovascular diseases (CVD) remain the leading cause of death worldwide. Although CVD mortality declined substantially over the past five decades\, progress in the United States has slowed since 2010. Reviving these gains will require more effective implementation of prevention strategies\, including improved methods for identifying individuals at highest risk. \nIn this presentation\, Dr. Goodarz Danaei will discuss emerging approaches to cardiovascular risk prediction and prevention\, including the use of causal inference methods and nationally representative data to develop more accurate risk models. He will explore the limitations of existing prediction tools\, which often rely on outdated cohort studies or nonrepresentative electronic medical record data\, and present new research aimed at improving population-level prevention strategies in the United States and globally. \nThis webinar is free and open to the public and will include time for audience Q&A. \nRegister \n  \nSpeaker\n \nGoodarz Danaei\, MD\nBernard Lown Professor of Cardiovascular Health\, Global Health and Population\, Harvard T.H. Chan School of Public Health; Faculty Director\, Bernard Lown Scholars in Cardiovascular Health Program \nDr. Goodarz Danaei is the Bernard Lown Professor of Cardiovascular Health in the Department of Global Health and Population at the Harvard T.H. Chan School of Public Health. His global health research focuses on quantifying the population-level impact of risk factors and preventive interventions on cardiovascular disease globally\, with a focus on low- and middle-income countries. He led the team that developed the only country-level risk prediction model for cardiovascular disease (www.globorisk.org) that has since been used by dozens of researchers and clinical groups worldwide. His epidemiological research applies advanced methods of causal inference to emulate the design and analysis of target trials using electronic health records and other observational data. As a member of CAUSALab\, he has helped develop and apply marginal Structural Models and the G-formula to quantify causal effects of lifestyle changes or medications on long-term risk of cardiovascular diseases. \n  \nGlobal Health Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nThe Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the institute or the university.
URL:https://globalhealth.harvard.edu/event/research-innovation-goodarz-danaei/
LOCATION:Zoom\, Virtual: Zoom
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2026/01/Ruanne-Barnabas-RI-Speaker-Series-Promo-Image-900x600-28.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260210T120000
DTEND;TZID=UTC:20260210T124500
DTSTAMP:20260821T053857
CREATED:20260105T213905Z
LAST-MODIFIED:20260123T160808Z
UID:10001043-1770724800-1770727500@globalhealth.harvard.edu
SUMMARY:Aging in Place: The Care Challenge
DESCRIPTION:  \nAround the world\, most people\, when asked\, say that as they age they want to stay at home in their own community rather than move into an institution. This preference raises a challenge once people need additional care and assistance: how can it be provided? Much work has focused on maintaining people’s health and increasing the supply of caregivers\, but this session examines how environments might be supportive and provide settings for both mutual support among older adults and care technologies. \nIn this webinar\, Professor Ann Forsyth examines aging in place through the lens of the built environment. Moving beyond traditional approaches focused on health maintenance and caregiver supply\, she explores how physical environments can support older adults and address the care challenges of an aging population. \nThis event is free and open to the public and will include time for audience Q&A. \nRegister \n  \nSpeaker\n \nAnn Forsyth\, PhD\, MA\nRuth and Frank Stanton Professor of Urban Planning\, Harvard University \nTrained in planning and architecture\, Ann Forsyth is a professor of urban planning at the Harvard Graduate School of Design\, focusing on the social aspects of physical planning and urban development. The big issue behind her research and practice is how to make more sustainable and healthy cities. Professor Forsyth’s current research focuses on developing healthier places in a suburbanizing world\, with overlapping emphases on aging and planned communities. Her education includes a B.Sc. in architecture from the University of Sydney\, M.A. in urban planning from UCLA\, and Ph.D. in city and regional planning from Cornell. \n  \n  \nAbout the Global Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nThe Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the institute or the university.
URL:https://globalhealth.harvard.edu/event/research-innovation-ann-forsyth/
LOCATION:Zoom\, Virtual: Zoom
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2026/01/Ruanne-Barnabas-RI-Speaker-Series-Promo-Image-900x600-22.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20251209T120000
DTEND;TZID=UTC:20251209T124500
DTSTAMP:20260821T053857
CREATED:20251114T211609Z
LAST-MODIFIED:20251117T155931Z
UID:10001029-1765281600-1765284300@globalhealth.harvard.edu
SUMMARY:Neuropsychiatric Genetics in African Populations: Lessons from the Past Decade and Future Directions
DESCRIPTION:  \nOver the past decade\, the Neuropsychiatric Genetics of African Populations (NeuroGAP) initiative has transformed how scientists understand the genetic foundations of mental health. In this talk\, Dr. Karestan Koenen will share insights from this landmark research effort\, which spans Ethiopia\, Kenya\, South Africa\, and Uganda\, and reflects deep collaboration across institutions and communities. She will discuss what the field has learned about neuropsychiatric disorders through more inclusive research\, how these findings are reshaping global mental health science\, and where the next decade of discovery may lead. \nThis event highlights Dr. Koenen’s research and perspectives on expanding the global reach of psychiatric genetics to advance equity and understanding in mental health science and will include time for audience Q&A. This event is free and open to the public. \nRegister \n  \nSpeaker\n \nKarestan Koenen\, PhD\nProfessor of Psychiatric Epidemiology; Director of the Population Health Lab at Harvard TH Chan School of Public Health\, Director of the Broad Trauma Initiative at the Broad Institute of MIT and Harvard \nKarestan C. Koenen\, Ph.D.\, is a clinical psychologist\, epidemiologist\, and author. She is Professor of Psychiatric Epidemiology at the Harvard T.H. Chan School of Public Health where she aims to reduce the population burden of mental disorders. Dr. Koenen directs the Broad Trauma Initiative at the Broad Institute of MIT and Harvard where she is an Institute Member. She is passionate about using science to overcome violence and trauma\, which are major preventable causes of health problems globally.  She has written for the Boston Globe\, the Washington Post\, the Huffington Post\, Thrive Global and Psychology Today.  Her most recent book is Treating Survivors of Childhood Abuse and Interpersonal Trauma\, Second Edition: STAIR Narrative Therapy with Drs. Marylene Cloitre\, Kile Ortigo\, Lisa Cohen and Christie Jackson. \n  \nModerator\n \nGregory Fricchione\, MD\nDirector\, Benson-Henry Institute for Mind Body Medicine; Director Emeritus\, Division of Psychiatry and Medicine; Director Emeritus\, Pierce Global Division of Psychiatry; MGH Department of Psychiatry; Co-Director\, McCance Center for Brain Health\, Department of Neurology; Mind Body Medicine Professor of Psychiatry\, Harvard Medical School. \nA graduate of New York University School of Medicine and the NYU-Bellevue Psychiatry Residency and Chief Residency and the MGH Fellowship in Consultation Psychiatry\, Dr Fricchione has served on the staffs of Stony Brook University\, Auckland University in New Zealand\, Brigham and Women’s Hospital and Massachusetts General Hospital.  From 2000 to 2002\, he served as The Carter Center Mental Health Program Director for President and Mrs. Carter while on leave of absence from Harvard Medical School. He specializes in neuropsychiatry and psychosomatic medicine and for over 40 years has helped care for patients with severe medical\, neurological and surgical illnesses as a Consult Liaison psychiatrist. He has published more than 350 peer reviewed publications and has authored or co-authored 6 books including the 2011 Compassion and Healing in Medicine: On the Nature and Uses of Attachment Solutions for Separation Challenges (Johns Hopkins University Press) and the 2016 The Science of Stress (University of Chicago Press). He is also the medical editor of the Harvard Medical School Special Report on Stress Management. His research interests include study of the catatonic syndrome\, the neurophysiology of stress and resilience and how the comparative neurology of brain evolution illuminates our concepts of health and illness and medical caregiving. Dr. Fricchione was the Academy of Psychosomatic Medicine ACLP Hackett Award winner in 2017. \n  \nAbout the Global Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nThe Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the institute or the university.
URL:https://globalhealth.harvard.edu/event/neuropsychiatric-genetics-in-african-populations-lessons-from-the-past-decade-and-future-directions/
LOCATION:Zoom\, Virtual: Zoom
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2025/11/Ruanne-Barnabas-RI-Speaker-Series-Promo-Image-900x600-22.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20251104T120000
DTEND;TZID=UTC:20251104T124500
DTSTAMP:20260821T053857
CREATED:20251014T202143Z
LAST-MODIFIED:20251015T133055Z
UID:10001028-1762257600-1762260300@globalhealth.harvard.edu
SUMMARY:Rethinking American Indian Mental Health Services: Explorations in Alter-Native Psy-ence
DESCRIPTION:  \nSince the early stages of his career\, Joseph P. Gone has been examining depression and problem drinking within his own community on the Fort Belknap Indian Reservation in Montana. During this work\, he interviewed a cultural traditionalist named Traveling Thunder\, who linked substance abuse challenges to the historical and ongoing impacts of Euro-American colonization on community life. \nBuilding on these insights\, Professor Gone proposes an alternative Indigenous mental health discourse\, an “alter-Native psy-ence”\, that contests and recasts mainstream psychiatric concepts and reframes “mental health” problems as postcolonial disorders. \nThis event will highlight Professor Gone’s research and perspectives on rethinking American Indian mental health services and will include time for audience Q&A. This event is free and open to the public. \nRegister \n  \nSpeaker\n \nJoseph P. Gone\, PhD \nProfessor of Anthropology and of Global Health and Social Medicine; Faculty Director of the Harvard University Native American Program \nJoseph P. Gone is Professor of Anthropology and of Global Health and Social Medicine at Harvard University\, where he also serves as the Faculty Director of the Harvard University Native American Program. An international expert in the psychology and mental health of American Indians and other Indigenous Peoples\, Professor Gone has collaborated with tribal communities for 30 years to critique conventional mental health services and to harness traditional culture and spirituality for advancing Indigenous well-being. As a clinical-community psychologist and action researcher\, he has published over 100 scientific articles and received recognition in his fields through more than 25 fellowships and career awards\, including a Guggenheim Fellowship. Professor Gone is a graduate of Harvard College and the University of Illinois\, and he also trained at Dartmouth College and McLean Hospital/Harvard Medical School. He taught at the University of Michigan in Ann Arbor for sixteen years\, where he directed the Native American Studies program prior to joining the faculty at Harvard. An enrolled member of the Aaniiih-Gros Ventre Tribal Nation of Montana\, he also served briefly as the Chief Administrative Officer for the Fort Belknap Indian reservation. He is currently a Fellow of the Association for Psychological Science\, and of seven divisions of the American Psychological Association. In 2023\, Gone received a Gold Medal Award for Impact in Psychology from the American Psychological Foundation. He is an elected member of the National Academy of Medicine. \n  \nModerator\nVikram Patel\, M.B.\,B.S.\, Ph.D.\nPaul Farmer Professor and Chair of Global Health and Social Medicine in the Blavatnik Institute’s Department of Global Health and Social Medicine at Harvard Medical School \n  \nAbout the Global Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nThe Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the institute or the university.
URL:https://globalhealth.harvard.edu/event/event-rethinking-american-indian-mental-health-services/
LOCATION:Zoom\, Virtual: Zoom
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2025/10/Ruanne-Barnabas-RI-Speaker-Series-Promo-Image-900x600-17.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250930T120000
DTEND;TZID=America/Halifax:20250930T124500
DTSTAMP:20260821T053857
CREATED:20240530T191626Z
LAST-MODIFIED:20250904T154244Z
UID:10000989-1759233600-1759236300@globalhealth.harvard.edu
SUMMARY:The Ethics of Priority Setting in Global Health
DESCRIPTION:  \n \n  \nProfessor Ole Norheim will discuss the ethical challenges of priority setting in global health\, with a focus on advancing universal health coverage in low- and middle-income countries. Despite significant progress in reducing child and maternal mortality over the past 25 years\, many nations continue to face difficult choices about how to allocate limited health resources fairly and effectively. This session will examine frameworks for balancing equity\, efficiency\, and ethical responsibility in health policy decision-making. By highlighting approaches that promote fairness while addressing real-world constraints\, the discussion will shed light on how global health systems can move toward more just and sustainable coverage for all. A Q&A will follow the presentation. \nThis event is free and open to the public. \nRegister \n  \n \nOle Norheim\, MD\nMary B. Saltonstall Professor of Ethics and Population Health at the Department of Global Health and Population\, HSPH \nOle Norheim is a physician and Mary B. Saltonstall Professor of Ethics and Population Health at the Department of Global Health and Population\, Harvard T. H. Chan School of Public Health. He co-founded the Bergen Centre for Ethics and Priority Setting in Health at the University of Bergen\, Norway\, and is an Adjunct Researcher at the centre. He is the Lead Series Editor of Disease Control Priorities (fourth edition) and a member of the Lancet Commission on Sustainable Healthcare. Norheim chaired the World Health Organization’s Consultative Group on Equity and Universal Health Coverage (2012–14) and its Technical Advisory Board on Health Benefit Packages (2019-21). \n  \n  \nAbout the Global Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nThe Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the institute or the university.
URL:https://globalhealth.harvard.edu/event/research-and-innovation-ole-norheim/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/05/Ruanne-Barnabas-RI-Speaker-Series-Promo-Image-900x600-4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250909T120000
DTEND;TZID=America/Halifax:20250909T124500
DTSTAMP:20260821T053857
CREATED:20250820T155722Z
LAST-MODIFIED:20250820T160134Z
UID:10000301-1757419200-1757421900@globalhealth.harvard.edu
SUMMARY:Randomized Trial of Single-Dose HPV Vaccination in Young Women: 54-Month Efficacy and Durability
DESCRIPTION:  \nProfessor Ruanne Barnabas will present findings from the KEN SHE Study\, a randomized trial in Kenya assessing the efficacy of a single-dose HPV vaccine among young women. At 54 months of follow-up\, the study demonstrates lasting protection against HPV infection\, providing key evidence that shaped the World Health Organization’s updated guidelines recommending one or two doses for adolescents ages 9–20. The session will explore how a simplified vaccination schedule could transform cervical cancer prevention worldwide\, particularly in low- and middle-income countries where access to multi-dose regimens is limited. By reducing barriers to vaccination\, this approach has the potential to expand coverage\, promote equity\, and accelerate progress toward global cervical cancer elimination. A Q&A will follow the presentation. \nThis event is free and open to the public. \nRegister \n  \n \nRuanne Barnabas\, MBChB\, PhD\nChief of the Division of Infectious Diseases at MGH; Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health \nDr. Ruanne Barnabas is a South African physician scientist\, the Chief of the Division of Infectious Diseases at Massachusetts General Hospital (MGH)\, and Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health. \nOver that last 15 years her research has focused on interventions for HIV and STD treatment and prevention\, and\, more recently on COVID-19 prevention. She is the Protocol Chair of the KEN SHE Study to assess the impact of single-dose human papillomavirus (HPV) vaccination in Kenya. The ultimate aim of her work is to identify effective and scalable HIV\, HPV\, and infectious disease treatment and prevention strategies to increase access across diverse communities and promote equity in health. \nIn addition to leading clinical trials and companion health economic modeling as an independently funded investigator\, she also serves as an advisor to the World Health Organization and UNAIDS on cervical cancer elimination and treatment and prevention of HIV. She was honored as a Fellow of the Infectious Diseases Society of America in 2020. She has over 130 peer reviewed publications. \n\nAbout the Global Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nThe Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the institute or the university.
URL:https://globalhealth.harvard.edu/event/research-and-innovation-ruanne-barnabas/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/05/Ruanne-Barnabas-RI-Speaker-Series-Promo-Image-900x600-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250610T120000
DTEND;TZID=America/Halifax:20250610T124500
DTSTAMP:20260821T053857
CREATED:20250528T200649Z
LAST-MODIFIED:20250624T144248Z
UID:10000288-1749556800-1749559500@globalhealth.harvard.edu
SUMMARY:Sentinel: Strengthening Surveillance Capacity in West Africa for Preparedness and Response
DESCRIPTION:  \n \n  \nDr. Al Ozonoff\, Senior Advisor to the Director of Pandemic Preparedness at the Broad Institute and Associate Professor at Harvard Medical School\, will present an overview of Sentinel\, a collaborative initiative between the Broad Institute and the Institute of Genomics and Global Health in Nigeria. This program aims to strengthen outbreak preparedness and response in West Africa by building local capacity in Nigeria and Sierra Leone. Through the deployment of low-cost diagnostics\, real-time data systems\, and genomic surveillance training\, Sentinel empowers local scientists and public health leaders to respond more effectively to infectious disease threats. The session will highlight how strategic investments in regional surveillance networks can drive more resilient\, equitable global health systems. \nThis event is free and open to the public. \nRegister \n  \n \nAl Ozonoff\, PhD\nSenior Advisor to Pardis Sabeti\, Director of Pandemic Preparedness at the Broad Institute; Associate Professor at HMS \nDr. Al Ozonoff is a researcher trained in mathematics\, statistics\, epidemiology\, and data science\, focused on improving population health through better surveillance of disease. His work spans public health\, infectious disease\, and hospital-based surveillance. He has over two decades of research experience and has co-authored more than 200 peer-reviewed publications. Dr. Ozonoff completed his doctoral training in mathematics at UC Santa Barbara and his postdoctoral work in biostatistics at the Harvard School of Public Health. He has led multiple federally funded projects\, including a CDC project on methods for syndromic surveillance and an AHRQ-funded project to conduct patient safety surveillance using machine learning. During the COVID-19 pandemic\, he directed the Clinical and Data Coordinating Center for IMPACC\, a national immunophenotyping study funded by the NIH. At the Broad\, he directs the Sentinel program which aims to strengthen surveillance capacity in West Africa. \n  \n\n\nAbout the Global Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nThe Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the institute or the university.
URL:https://globalhealth.harvard.edu/event/research-and-innovation-dr-ozonoff-june/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/05/unnamed-file.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250513T120000
DTEND;TZID=America/Halifax:20250513T124500
DTSTAMP:20260821T053857
CREATED:20250424T185638Z
LAST-MODIFIED:20250424T191827Z
UID:10000284-1747137600-1747140300@globalhealth.harvard.edu
SUMMARY:Reflections on Mental Health Work in Post-Conflict Aceh\, 2004-2024
DESCRIPTION:Professor Byron Good will present “Reflections on Mental Health Work in Post-Conflict Aceh\, 2004–2024\,” drawing on two decades of experience in the region. Following the devastating 2004 tsunami that struck Aceh and revealed an ongoing civil conflict to the international community\, a peace accord was signed in 2005 that ended much of the violence. In the years that followed\, Professor Good and Professor Mary-Jo Good partnered with the International Organization for Migration to lead mental health initiatives in the post-conflict areas. This included a large-scale Psychosocial Needs Assessment and the development of mental health outreach teams serving 75 villages. In this session\, Professor Good will share insights from the program’s implementation and outcomes\, and reflect on the enduring role and impact of mental health interventions in post-conflict recovery. \nThis event is free and open to the public.  \nRegister \n  \n Byron Good\, PhD\, BD \nProfessor of Medical Anthropology\, Department of Global Health and Social Medicine\, Harvard Medical School\, and Department of Anthropology\, Harvard University \nProfessor Good is a medical\, psychological and psychiatric anthropologist. Professor Good has been carrying out research focused on subjectivity\, culture and mental illness in Indonesia since 1996 – on studies of psychosis and the development of mental health services in Yogyakarta\, Java\, and on humanitarianism and mental health responses to traumatic violence in Aceh. He has conducted and led studies of early experiences of psychosis in Indonesia\, as well as comparative projects of first episode psychosis in Indonesia\, China\, Hong Kong\, and the United States. \nProfessor Good gave the 2000 Lewis Henry Morgan Lectures and Oxford University’s 2010 Marett Lecture. He was awarded the Society for Medical Anthropology’s Lifetime Mentoring Award in 2000 and the Society for Psychological Anthropology’s Lifetime Achievement Award in 2017. He was the President of the Society for Psychological Anthropology 2013-2015. He served as Editor-in-Chief of the journal Culture\, Medicine and Psychiatry 1986-2004. \n  \nAbout the Global Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nThe Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the institute or the university.
URL:https://globalhealth.harvard.edu/event/research-and-innovation-professor-good/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/05/9.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250408T120000
DTEND;TZID=America/Halifax:20250408T124500
DTSTAMP:20260821T053857
CREATED:20250306T161404Z
LAST-MODIFIED:20250306T161407Z
UID:10000279-1744113600-1744116300@globalhealth.harvard.edu
SUMMARY:LEAPS: A 2-Generation Approach for Early Childhood and Youth Development
DESCRIPTION:  \n \n  \nIn Pakistan\, millions of young children lack access to quality early childhood education\, while young women face limited opportunities for training and employment. LEAPS\, a youth-led program led by Professor Aisha K. Yousafzai\, trains female youth to deliver early education in underserved communities — creating a powerful two-generation impact. In this session\, Professor Yousafzai will share key findings from LEAPS\, highlighting how this innovative approach strengthens child development\, empowers young women\, and offers valuable lessons for global health\, education\, and workforce development programs. \nThis event is free and open to the public.  \nRegister \n  \nAbout the Speaker\n \nAisha K. Yousafzai\, PhD \nProfessor of Child Development and Health in the Department of Global Health and Population at the Harvard T.H. Chan School of Public Health \nProfessor Yousafzai’s research focuses on promoting the well-being of children and the stability of families among disadvantaged and vulnerable populations in low- and middle-income countries\, with a special focus on south Asia\, and east and southern Africa. She examines both child development and systems as a whole\, specifically showing how interventions that can promote early childhood development can be mainstreamed effectively into these existing systems. One of Professor Yousafzai’s most significant studies is the Pakistan Early Child Development Scale-Up (PEDS) trial\, a cluster randomized controlled trial evaluating responsive stimulation and nutrition interventions to strengthen early child development and growth outcomes. Professor Yousafzai has written extensively about early childhood interventions in low- and middle-income countries including recent articles in Annals of the New York Academy of Science\, Annual Review of Psychology\, Lancet\, Lancet Global Health\, and Pediatrics. She also serves on a number of Advisory Groups on early child development for international organizations including UNICEF and the Early Childhood Development Action Network. \n  \nAbout the Global Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nSpeakers will share their own perspectives; they do not speak for Harvard.
URL:https://globalhealth.harvard.edu/event/research-and-innovation-professor-yousafzai/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/05/1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250311T120000
DTEND;TZID=America/Halifax:20250311T124500
DTSTAMP:20260821T053857
CREATED:20250211T212100Z
LAST-MODIFIED:20250212T214938Z
UID:10000275-1741694400-1741697100@globalhealth.harvard.edu
SUMMARY:Innovation to Transform Underperforming Health Systems
DESCRIPTION:  \nHealth systems worldwide face multiple and converging challenges: epidemiological transition leading to rising burden of disease and disability\, rising demand for health services\, higher societal expectations\, increasing health expenditures\, slow economic growth and fiscal conservatism with austerity policies that constrain investment in health systems. Innovation is critical for fundamental transformation of health systems to overcome these challenges\, build responsiveness and resilience\, and ensure sustainability. This session will present an analysis of health systems responses to evolving challenges and identify areas of major underperformance. It will explore emerging innovations that could be harnessed to transform health systems to improve population health outcomes and societal wellbeing. \nThis event is free and open to the public.  \nRegister \n  \nAbout the Speaker\n \nRifat Atun\, MBBS\, MBA\, FFPH\, FRCGP\, FRCP \nProfessor of Global Health Systems in the Department of Global Health and Population at Harvard T.H. Chan School of Public Health \nRifat Atun is Professor of Global Health Systems at Harvard University and the Director of The Health System Innovation Lab. In 2015-2023 he was the Faculty Chair for the Harvard Ministerial Leadership Program. He is a Faculty Affiliate at the Center for International Development at the Harvard Kennedy School\, and Faculty and Member of the Harvard University Asia Center Steering Committee and Council. Professor Atun is a Visiting Professor at Imperial College London\, and a Distinguished Visiting Professor at Fukushima University in Japan. \nProfessor Atun has published more than 450 papers in leading journals including the Lancet\, NEJM\, Nature Medicine\, Academy of Management Journal\, Lancet Global Health\, Lancet Infectious Diseases\, Lancet Oncology\, and Lancet Psychiatry. In 2020\, 2021\, 2022\, 2023\, and 2024 he was recognized by the Web of Science/Clarivate as one of the World’s Highly Cited Researchers. \nProfessor Atun has worked with more than 30 governments globally and with the World Bank\, World Health Organization\, and the UK Department for International Development (DfID) to design\, implement and evaluate health system reform initiatives. In 1999-2006 he was a member of the UK DfID Resource Centre for Health Systems. Professor Atun has led executive education programs and undertaken assignments for major organizations including Novartis\, Medtronic\, GSK\, Pfizer Inc.\, the Vodafone Group\, and Hofmann-La Roche. \n  \nAbout the Global Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nSpeakers will share their own perspectives; they do not speak for Harvard.
URL:https://globalhealth.harvard.edu/event/research-and-innovation-rifat-atun/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/05/Eram-Alam-Social-Post-1-4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250211T100000
DTEND;TZID=America/Halifax:20250211T104500
DTSTAMP:20260821T053857
CREATED:20250114T171553Z
LAST-MODIFIED:20250122T144542Z
UID:10000271-1739268000-1739270700@globalhealth.harvard.edu
SUMMARY:The History and Challenges of Immigrant Physicians in the US Healthcare System
DESCRIPTION:  \nSince the 1960s\, the United States has relied on soliciting immigrant physicians to fill vacancies due to the shortage of U.S.-trained doctors. In this talk\, Professor Eram Alam will examine the reasons behind this physician migration and how this migratory flow continues to influence US healthcare dynamics. The widespread and essential presence of foreign physicians in the U.S. highlights not only the racial dynamics within the US healthcare system but also illustrates the broader workings of the political economy of healthcare in our globalized era. \nThis event is free and open to the public.  \nRegister \n  \nAbout the Speaker\n \nEram Alam\, PhD\, Assistant Professor of the History of Science\, Harvard University \nEram Alam is an Assistant Professor of the History of Science at Harvard University. Her research is primarily concerned with the history of medicine\, with a particular emphasis on globalization\, race\, migration\, and health during the twentieth century. Her first book\, The Care of Foreigners: How Immigrant Physicians Changed US Healthcare\, explores the enduring consequences of post-colonial physician migration from Asia to the United States since 1965. Her next project\, Patients Without Borders\, is also inspired by mobility regimes and traces US patient movement to sites outside of the country for medical care. As access to routine care such as hip replacements or dental services becomes more convoluted and fragmented\, the project asks: how have medical travel patterns and routes to certain countries emerged and stabilized? \n  \n  \n  \nAbout the Moderator\n \nDavid S. Jones\, MD\, PhD\, A. Bernard Ackerman Professor of the Culture of Medicine at Harvard Medical School and in the History of Science at Harvard Faculty of Arts and Sciences; Professor of Epidemiology at the Harvard T.H. Chan School of Public Health \nTrained in psychiatry and history of science\, David Jones is the Ackerman Professor of the Culture of Medicine at Harvard University. His research has focused on the causes and meanings of health inequalities (Rationalizing Epidemics: Meanings and Uses of American Indian Mortality since 1600) and the history of decision making in cardiac therapeutics (Broken Hearts: The Tangled History of Cardiac Care). He is currently at work on four other histories\, of the evolution of coronary artery surgery\, of heart disease and cardiac therapeutics in India\, of the threat of air pollution to health in India\, and of the history of air pollution research in the United States. His teaching at Harvard College and Harvard Medical School explores the history of medicine\, medical ethics\, and social medicine. \n  \n  \n  \nAbout the Global Health Research & Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nSpeakers will share their own perspectives; they do not speak for Harvard.
URL:https://globalhealth.harvard.edu/event/alam-research-innovation/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2025/01/Alam-Speaker-Series-Banner-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241210T120000
DTEND;TZID=America/Halifax:20241210T124500
DTSTAMP:20260821T053857
CREATED:20241126T204735Z
LAST-MODIFIED:20241209T190819Z
UID:10000963-1733832000-1733834700@globalhealth.harvard.edu
SUMMARY:Health System and Reform: China's Experience
DESCRIPTION:In 2009\, China launched a major healthcare reform with the goal to provider universal and equitable access to basic healthcare for its residents. Since then\, China has expanded social insurance coverage to over 96% of its population\, improved access to care and moderately reduced health inequality. However\, the system is confronted with the challenges of rapid cost escalation\, an aging population\, increase non-communicable disease burden and slowed economic growth. \nJoin Professor Winnie Yip\, Professor of Global Health and Economics at the Harvard T.H. Chan School of Public Health and the Faculty Director of the school wide Harvard China Health Partnership\, for a talk about her research on health system reform in China. This seminar analyzes China’s success and challenges in ensuring universal and equitable basic healthcare\, examines strategies for responding to the challenges and draw lessons for other countries in the quest for universal health coverage. Dr. Louise Ivers will moderate the discussion.  \nThe event is free and open to the public. \nAbout the Speakers\n\nWinnie Yip\, Professor of the Practice of Global Health Policy and Economics\, Harvard T.H. Chan School of Public Health \nDr. Winnie Yip is currently Professor of Global Health Policy and Economics at the Harvard T.H. Chan School of Public Health\, and the Faculty Director of the school wide Harvard China Health Partnership. In addition to her academic appointments\, Dr. Yip is a member of the National Committee on US China Relations (NCUSCR) Track II Health Dialogues\, served as the past President of the International Health Economics Association (iHEA)\, and has consulted for numerous international agencies including the World Bank and the World Health Organization. Dr. Yip holds a PhD in Economics from the Massachusetts Institute of Technology. \nHer research focuses on rigorous and policy-relevant health system evaluations and the design and testing of innovative health system interventions to improve equitable access to efficient and good quality health care. She applies this approach to developing viable and effective models of population health based integrated delivery systems in China and India. She is also interested in the implications of China’s ageing population for the country’s health system and in designing and piloting innovative eldercare systems to support older adults in living meaningful lives. Dr. Yip has studied and advised health care reforms in the wider Asia region\, including Hong Kong\, Taiwan\, Thailand\, Malaysia and Vietnam. \n  \n  \n \nLouise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy.
URL:https://globalhealth.harvard.edu/event/health-system-and-reform-chinas-experience/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/11/Professor-Yip-RI-Speaker-Series-Mailchimp-Banner-900-x-600px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241112T120000
DTEND;TZID=America/Halifax:20241112T124500
DTSTAMP:20260821T053857
CREATED:20241008T144127Z
LAST-MODIFIED:20241121T220229Z
UID:10000830-1731412800-1731415500@globalhealth.harvard.edu
SUMMARY:Advancing Global Adolescent Health and Nutrition: Insights from the ARISE Network
DESCRIPTION:  \nAdequate nutrition during adolescence can profoundly impact health and well-being in the present\, continuing into adulthood\, and extending to future generations. Evidence from our recent observational and intervention studies demonstrates the effectiveness of integrated approaches in mitigating malnutrition. Dr. Fawzi’s will discuss his research which focuses on addressing pressing health challenges in countries such as Tanzania\, Uganda\, Sudan\, and India. His primary interests include the design and implementation of randomized controlled trials and observational studies targeting maternal\, neonatal\, and child health\, as well as infectious diseases\, with a special emphasis on the role of nutrition. Dr. Louise Ivers will moderate the session. \nThe event is free and open to the public. \nAbout the Speakers\n\nWafaie Fawzi\, MBBS\, MPH\, MS\, DrPH\, Professor of Nutrition\, Epidemiology\, and Global Health at Harvard T.H. Chan School of Public Health \nWafaie Fawzi\, MBBS\, MPH\, MS\, DrPH is a physician and epidemiologist focused on advancing global health research\, education\, and practice. He is Professor of Nutrition\, Epidemiology\, and Global Health at Harvard T.H. Chan School of Public Health. He established and continues to lead the Nutrition and Global Health Program\, an interdepartmental initiative at Harvard where over the past 25 years he sought to strengthen the evidence base for advancing human health and development. He is an elected member of the National Academy of Medicine. \n  \n  \n \nLouise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy.
URL:https://globalhealth.harvard.edu/event/advancing-global-adolescent-health-and-nutrition/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/10/Dr.-Fawzi-RI-Speaker-Series-Promo-Image-900-x-600px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241008T120000
DTEND;TZID=America/Halifax:20241008T124500
DTSTAMP:20260821T053857
CREATED:20240910T153534Z
LAST-MODIFIED:20241112T211448Z
UID:10000819-1728388800-1728391500@globalhealth.harvard.edu
SUMMARY:Hunger\, Food Security\, and the Race to Produce New Seeds for a Climate-Changed World
DESCRIPTION:Many of the world’s most productive agricultural regions are increasingly vulnerable to extreme droughts\, floods\, and unpredictable weather patterns. As climate change forces farmers to migrate and adapt\, the ripple effects on global food systems and public health will be felt for decades. In response\, crop research centers are racing to develop new seed varieties that can withstand these harsh conditions. Drawing on lessons from the mid-twentieth century efforts to rapidly increase food production\, this session explores the urgent need for innovation in food production\, highlighting the long-term impacts on the environment\, health\, and food security. Dr. Gabriela Soto Laveaga will discuss how this race for resilience will shape the future of global health and well-being. Dr. Megan Murray will moderate the conversation. \nThe event is free and open to the public. \nAbout the Speakers\n \nGabriela Soto Laveaga\, PhD\, MA\, Professor of the History of Science and Antonio Madero Professor for the Study of Mexico at Harvard University \nGabriela Soto Laveaga is Professor of the History of Science and Antonio Madero Professor for the Study of Mexico at Harvard University. Her award-winning first book Jungle Laboratories: Mexican Peasants\, National Projects and the Making of the Pill narrated the impact of the search for medicinal plants at the local\, national\, and global level. Her award-wining articles have ranged from examining the role of indigenous midwives in the Mexican healthcare system\, the use of soap operas to deliver public health messaging\, Latin American innovation in science and medicine\, and how we narrate histories of science outside of so-called centers of innovation. She is completing two book manuscripts: one on doctors as agents of social unrest and her third book which examines agricultural science exchange between India and Mexico. She has been a fellow at the Institute of Advanced Study at Princeton\, held the Dibner Distinguished fellowship in History of Science and Technology at the Huntington Library\, among other awards. Most recently she was elected to the Academia Mexicana de la Historia\, one of the highest honors for a historian of Mexico\, especially one outside of the country. She is also a past recipient of the Everett Mendelsohn Excellence in Graduate Mentoring Award. \n  \n \nMegan Murray\, ScD\, MD\, Ronda Stryker and William Johnston Professor of Global Health\, Harvard Medical School; Director of Research\, Global Health & Social Medicine\, Harvard Medical School \nMegan Murray is an epidemiologist and an infectious disease physician\, with over 25 years of experience studying tuberculosis and other infectious diseases. She received her MD from Harvard Medical School in 1990 and completed her residency in internal medicine and a fellowship in Infectious Disease at Massachusetts General Hospital. She received her ScD in Epidemiology from the Harvard School of Public Health in 2000. She currently serves as the Ronda Stryker and William Johnston Professor of Global Health and Social Medicine at Harvard Medical School and as a Professor of Epidemiology at the Harvard Chan School of Public Health. \nDr. Murray’s research focuses on social\, host and pathogen specific determinants of TB infection\, disease and treatment outcomes. She studies nutritional risk factors for TB infection and disease\, including macronutrients status and the role of Vitamins A\, E and D. She uses bacterial and human genetic and genomic tools to identify variants of interest and their role in TB. \n  \nAbout the Global Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nSpeakers will share their own perspectives; they do not speak for Harvard.
URL:https://globalhealth.harvard.edu/event/hunger-food-security-and-the-race-to-produce-new-seeds/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/09/Soto-RI-Speaker-Series-Mailchimp-Image-Template-900-x-600px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240910T120000
DTEND;TZID=America/Halifax:20240910T124500
DTSTAMP:20260821T053857
CREATED:20240827T142350Z
LAST-MODIFIED:20240828T150140Z
UID:10000249-1725969600-1725972300@globalhealth.harvard.edu
SUMMARY:Impact of Arbovirus Infection on Pregnancy
DESCRIPTION:  \n \nThe adverse impact of Zika (ZIKV)\, dengue (DENV)\, and chikungunya (CHIKV) virus infection in pregnancy has been recognized in Latin America and Asia but is not well studied in Africa. Although originally discovered in sub-Saharan Africa\, the non-specific clinical presentation of arbovirus infection may have hampered our detection of adverse clinical outcomes and outbreaks. This prospective study of arbovirus infection in pregnant women in north-central Nigeria sought to characterize the prevalence of acute arbovirus infection and determine the impact on pregnancy and infant outcomes. \nDr. Phyllis Kanki will talk about her research on this important topic and attendees are encouraged to join the discussion by sending us their questions. Dr. Louise Ivers will moderate the conversation. \nThe event is free and open to the public. \nAbout the Speakers\n\nPhyllis Kanki\, DVM\, DSc\, Mary Woodard Lasker Professor of Health Sciences \nPhyllis Kanki is the Mary Woodard Lasker Professor of Health Sciences at the Harvard T. H. Chan School of Public Health. She has worked in West Africa since 1984\, where her research in Senegal provided the initial characterization of HIV-2\, demonstrated reduced virulence\, transmission and progression to disease and interactions with HIV-1 subtypes. In 2000\, she founded the AIDS Prevention Initiative in Nigeria (APIN)\, supported by the Bill & Melinda Gates Foundation modeled after the Senegal research collaboration. She led Harvard’s President’s Emergency Plan for AIDS Relief (PEPFAR) program supporting prevention\, care and HIV antiretroviral therapy for over 200\,000 patients in Nigeria\, Botswana\, and Tanzania (2005-2013). In West Africa\, following epidemics of Ebola (EBOV) and Zika virus (ZIKV)\, she documented the multi-decade presence of ZIKV\, demonstrating the endemicity of this unique arbovirus in the region. She described the longevity\, specificity and cross reactivity of T cell responses to ZIKV and DENV and characterized the T cell responses in survivors and exposed health care workers from the 2015 Nigeria EBOV outbreak. She has just completed a 3 year study of ZIKV\, dengue and Chikungunya virus infection in pregnant women and documenting associated microcephaly and other birth abnormalities. \n  \n \nLouise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy.
URL:https://globalhealth.harvard.edu/event/research-and-innovation-speaker-series-2024-09-10/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/08/Phyllis-Kanki-RI-Speaker-Series-Promo-Image-900-x-600-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240618T120000
DTEND;TZID=America/Halifax:20240618T124500
DTSTAMP:20260821T053857
CREATED:20240605T145532Z
LAST-MODIFIED:20240617T204743Z
UID:10000233-1718712000-1718714700@globalhealth.harvard.edu
SUMMARY:Climate Change and Respiratory Health: From Epidemiology to Intervention
DESCRIPTION:  \n \nDr. Mary B. Rice will discuss research on the respiratory health effects of climate change and opportunities for physicians and scientists to intervene at the clinical and policy level. \nDr. Satchit Balsari will moderate the session\, with an introduction by Dr. Louise C. Ivers. \nThis event is free and open to the public. \nAbout the Speakers\n \nMary B. Rice\, MD\, MPH\, Director of the BIDMC Institute for Lung Health\, Associate Professor of Medicine at Harvard Medical School \nDr. Rice’s research focuses on preventable causes of chronic lung disease in children and adults\, including environmental exposures such as air pollution\, climate\, aeroallergens and microbes. Dr. Rice is the Director of the BIDMC Institute for Lung Health\, a multi-disciplinary respiratory research program that applies advanced statistical and sampling methodologies in clinical populations with chronic lung disease and multiple U.S.-based prospective cohort studies of children and adults. A core mission is to identify preventable causes of chronic lung disease\, and to translate research findings into patient care and health policies that improve lung health. Dr. Rice’s research is funded by the National Institutes of Health. \n  \n  \n \nSatchit Balsari\, MD\, MPH\, Associate Professor\, Emergency Medicine\, Harvard Medical School and Beth Israel Deaconess Medical Center; Department of Global Health and Population\, Harvard T.H. Chan School of Public Health \nDr. Satchit Balsari is Associate Professor in Emergency Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center; and in the Department of Global Health and Population at the Harvard T.H. Chan School of Public Health. Dr. Balsari’s research and teaching are focused on complex humanitarian emergencies and digital health implementation science in resource-poor settings. He has worked with populations affected by disaster\, war and the COVID-19 pandemic in Iraq\, South Sudan\, Jordan\, Haiti\, Puerto Rico and across South Asia. In the most vulnerable communities in the world\, his team has leveraged cutting-edge digital tools and citizen science to advance public health planning\, advocacy\, and response. \nThe Balsari Lab collaborates directly with populations in distress\, humanitarian response agencies\, civil society organizations\, governments\, and international agencies\, to reduce the information asymmetry that threatens to exclude the poor and disadvantaged from decisions that will impact their lives. Dr. Balsari co-directs CrisisReady.io\, a research-response platform that builds data-driven decision tools for local communities and response agencies affected by disasters globally. Dr. Balsari is founding director of the tri-institute Climate and Human Health fellowship at Harvard\, leads the climate platform at the Lakshmi Mittal and Family South Asia Institute\, and is co-investigator on the Salata Institute’s inaugural interfaculty cluster grant on Climate Change Adaptation in South Asia. He recently has curated an exhibition\, Hum Sab Ek\, which is based on his research on the impact of the COVID-19 pandemic on the 2.9 million-strong Self Employed Women’s Association (SEWA)\, and its members’ response to it. \nPrior signature initiatives include EMcounter (a customizable\, portable digital surveillance tool\, the latest iteration of which was used at the world’s largest mass gathering\, the Kumbh Mela in India) and Voices\, a crowd-sourced\, online disaster response analysis tool. In 2018\, in collaboration with Professor Caroline Buckee (Epidemiology)\, he co-led the Hurricane Maria Mortality Study. \n  \n \nLouise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy.
URL:https://globalhealth.harvard.edu/event/research-and-innovation-speaker-series-3-2/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/06/Mary-Rice-6-18-2024-900-x-600px-no-QR-code.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240514T120000
DTEND;TZID=UTC:20240514T124500
DTSTAMP:20260821T053857
CREATED:20240506T132924Z
LAST-MODIFIED:20240506T152429Z
UID:10000227-1715688000-1715690700@globalhealth.harvard.edu
SUMMARY:Innovation in the Treatment of Drug-resistant Tuberculosis: The endTB Clinical Trial
DESCRIPTION:LEARN MORE/REGISTER \nIn this Global Health Research and Innovations Speaker Series event\, Dr. Carole Diane Mitnick\, ScD\, Professor of Global Health and Social Medicine at Harvard Medical School will share her work on the endTB clinical trial. Dr. Louise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director at the Harvard Global Health Institute\, will moderate the conversation. \nPLEASE CLICK HERE TO REGISTER \nEvent Description\nFor decades\, poor treatment options and low-quality evidence plagued care for rifampin-resistant tuberculosis (RR-TB). The advent of new anti-TB drugs and enhanced funding now permit randomized controlled trials of shortened\, all-oral treatment for resistant TB. \nMethods \nendTB is an international\, open-label\, Phase 3 non-inferiority\, randomized\, controlled clinical trial to compare five 9-month all-oral regimens including bedaquiline (B)\, delamanid (D)\, linezolid (L)\, levofloxacin (Lfx) or moxifloxacin (M)\, clofazimine (C) and pyrazinamide (Z)\, to the standard (control) for treatment of fluoroquinolone-susceptible RR-TB. Participants were randomized to 9BLMZ\, 9BCLLfxZ\, 9BDLLfxZ\, 9DCLLfxZ\, 9DCMZ and control using Bayesian response-adaptive randomization. The primary outcome was favorable outcome at week 73 defined by two negative sputum culture results or by favorable bacteriologic\, clinical\, and radiologic evolution. The non-inferiority margin was 12 percentage points. \nResults \nOf 754 randomized patients\, 696 and 559 were included in the modified intention to treat (mITT) and per-protocol (PP) analyses\, respectively. In mITT\, the control had 80.7% favorable outcomes. Regimens 9BCLLfxZ [adjusted risk difference (aRD): 9.5% (95% confidence interval (CI)\, 0.4 to 18.6)]\, 9BLMZ [aRD: 8.8% (95%CI\, -0.6 to 18.2)]\, and 9BDLLfxZ [3.9% (95%CI\, -5.8 to 13.6)] were non-inferior in mITT and in PP. The proportion of participants experiencing grade 3 or higher adverse events was similar across the regimens. Grade 3 or higher hepatotoxicity occurred in 11.7% of the experimental regimens overall and in 7.1% of the control. \nConclusions \nThe endTB trial increases treatment options for RR-TB with three shortened\, all-oral regimens that were non-inferior to a current well-performing standard of care. \nPLEASE CLICK HERE TO REGISTER \nAbout the Speakers\nCarole Diane Mitnick\, ScD\, Professor of Global Health and Social Medicine\, Harvard Medical School \nDr. Mitnick is Professor of Global Health & Social Medicine at Harvard Medical School (HMS) and Associate Epidemiologist in the Division of Global Health Equity at Brigham & Women’s Hospital. She has 25 years of experience in programmatic support\, research (observational and experimental)\, policy\, and advocacy related to increased access to high-quality\, appropriate treatment for TB\, especially for drug-resistant TB. Dr. Mitnick works in close collaboration with Partners In Health\, specifically in Peru\, Haiti\, Kazakhstan\, and Lesotho. In addition to teaching at HMS and giving lectures at other institutions\, Dr. Mitnick mentors trainees in the HMS Master of Medical Science in Global Health Delivery Program. She is the co-PI of the endTB and endTB-Q trials\, two multi-country\, Phase III\, randomized\, controlled\, clinical trials of all-oral\, shortened\, novel regimens for rifampin-resistant TB. She has also recently begun conducting research on post-TB lung disease. \nLouise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute; Executive Director\, Massachusetts General Hospital Center for Global Health \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy. \nAbout the Global Health Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nSpeakers will share their own perspectives; they do not speak for the university.
URL:https://globalhealth.harvard.edu/event/innovation-in-the-treatment-of-drug-resistant-tuberculosis-the-endtb-clinical-trial/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240409T120000
DTEND;TZID=America/Halifax:20240409T124500
DTSTAMP:20260821T053857
CREATED:20240312T124949Z
LAST-MODIFIED:20240517T195704Z
UID:10000219-1712664000-1712666700@globalhealth.harvard.edu
SUMMARY:Global Health Research and Innovation Speaker Series with Milind Tambe
DESCRIPTION:For over 15 years\, Dr. Tambe and his team have been focused on AI for social impact\, deploying end-to-end systems in areas of public health\, conservation\, and public safety. In this talk\, he will highlight the results from their deployments for social impact in public health\, as well as required innovations in integrating machine learning and optimization. Dr. Tambe will present recent results from their work in India with the world’s two largest mobile health programs for maternal and childcare that have served millions of beneficiaries\, and on-going projects focused on other mobile health programs. Additionally\, he will highlight results from an earlier project on HIV prevention among youth experiencing homelessness in Los Angeles. To address challenges of ML+optimization common to all of these applications\, Dr. Tambe and his team have advanced the state of the art in decision-focused learning\, restless multi-armed bandits and influence maximization in social networks. \nPLEASE CLICK HERE TO REGISTER \n  \nAbout Milind Tambe\, PhD\, MSc \nDr. Milind Tambe is Gordon McKay Professor of Computer Science and Director of Center for Research on Computation and Society at Harvard University; concurrently\, he is also Principal Scientist and Director for “AI for Social Good” at Google Research. Dr. Tambe is a recipient of the AAAI Award for Artificial Intelligence for the Benefit of Humanity\, AAAI Feigenbaum Prize\, IJCAI John McCarthy Award\, AAAI Robert S. Engelmore Memorial Lecture Award\, AAMAS ACM Autonomous Agents Research Award\, INFORMS Wagner prize for excellence in Operations Research practice\, Military Operations Research Society Rist Prize\, and the Columbus Fellowship Foundation Homeland security award. Dr. Tambe is a fellow of AAAI and ACM. Dr. Tambe’s work focuses on advancing AI and multiagent systems for public health\, conservation\, and public safety\, with a track record of building pioneering AI systems for social impact. \nYou can read more about Dr. Milind Tambe on his website\, X\, LinkedIn\, and Facebook. \n  \nAbout the Global Health Research and Innovation Speaker Series \nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nSpeakers will share their own perspectives; they do not speak for Harvard. \nPLEASE CLICK HERE TO REGISTER
URL:https://globalhealth.harvard.edu/event/global-health-research-and-innovation-speaker-series-with-milind-tambe/
LOCATION:Zoom\, Virtual: Zoom
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/03/Research-and-Innovations-Promo-Image-Landscape-1.png
END:VEVENT
END:VCALENDAR